Role of apical caspases and glucocorticoid-regulated genes in glucocorticoid-induced apoptosis of pre-B leukemic cells

Cancer Research

Volumn 63, Issue 1, 2003, Pages 172-178

  Planey, Sonia L ^a   Abrams, Marc T ^a   Robertson, Noreen M ^a   Litwack, Gerald ^a  

^a THOMAS JEFFERSON UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE; GLUCOCORTICOID;

APOPTOSIS; ARTICLE; CELL DEATH; CELL TYPE; DNA MICROARRAY; ENZYME ACTIVATION; ENZYME SPECIFICITY; GENE EXPRESSION REGULATION; GENE TARGETING; GENETIC REGULATION; HEMATOPOIETIC CELL; HUMAN; HUMAN CELL; LEUKEMIA CELL; PRIORITY JOURNAL; PROTEIN FAMILY; TISSUE SPECIFICITY;

EID: 0037226583     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (57)

1. Kumar, R., and Thompson, E. B. The structure of the nuclear hormone receptors. Steroids, 64: 310-319, 1999.
2. Pratt, W. B. The role of heat shock proteins in regulating the function, folding, and trafficking of the glucocorticoid receptor. J. Biol. Chem., 268: 21455-21458, 1993.
3. McEwan, I. J., Wright, A. P., and Gustafsson, J. A. Mechanism of gene expression by the glucocorticoid receptor: role of protein-protein interactions. Bioessays. 19: 153-160, 1997.
4. Gaynon, P. S., and Carrel, A. L. Glucocorticosteroid therapy in childhood acute lymphoblastic leukemia. Adv. Exp. Med. Biol., 457: 593-605, 1999.
5. Thomberry, N. A., and Lazebnik, Y. Caspases: enemies within. Science (Wash. DC), 281: 1312-1316, 1998.
6. Ashkenazi, A., and Dixit, V. M. Death receptors: signaling and modulation. Science (Wash. DC), 281: 1305-1308, 1998.
7. Saleh, A., Srinivasula, S. M., Acharya, S., Fishel, R., and Alnemri, E. S. Cytochrome c and dATP-mediated oligomerization of Apaf-1 is a prerequisite for procaspase-9 activation. J. Biol. Chem., 274: 17941-17945, 1999.
8. Li, H., Zhu, H., Xu, C. J., and Yuan, J. Cleavage of BID by caspase 8 mediates the mitochondrial damage in the Fas pathway of apoptosis. Cell, 94: 491-501, 1998.
9. Chandra, J., Niemer, I., Gilbreath, J., Kliche, K. O., Andreeff, M., Freireich, E. J., Keating, M., and McConkey, D. J. Proteasome inhibitors induce apoptosis in glucocorticoid-resistant chronic lymphocytic leukemic lymphocytes. Blood, 92: 4220-4229, 1998.
10. Haldar, S., Jena, N., DuBois, G. C., Takayama, S., Reed, J. C., Fu, S. S., and Croce, C. M. Purification and characterization of the bcl-2 protein. Arch. Biochem. Biophys., 315: 483-488, 1994.
11. Alnemri, E. S., Fernandes, T. F., Haldar, S., Croce, C. M., and Litwack, G. Involvement of BCL-2 in glucocorticoid-induced apoptosis of human pre-B leukemias. Cancer Res., 52: 491-495, 1992.
12. Yoshida, H., Kong, Y. Y., Yoshida, R., Elia, A. J., Hakem, A., Hakem, R., Penninger, J. M., and Mak, T. W. Apaf1 is required for mitochondrial pathways of apoptosis and brain development. Cell, 94: 739-750, 1998.
13. Kuida, K., Zheng, T. S., Na, S., Kuan, C., Yang, D., Karasuyama, H., Rakic, P., and Flavell, R. A. Decreased apoptosis in the brain and premature lethality in CPP32-deficient mice. Nature (Lond.), 384: 368-372, 1996.
14. Kullmann, M., Schneikert, J., Moll, J., Heck, S., Zeiner, M., Gehring, U., and Cato, A. C. RAP46 is a negative regulator of glucocorticoid receptor action and hormone-induced apoptosis. J. Biol. Chem., 273: 14620-14625, 1998.
15. Davis, R. J. Signal transduction by the JNK group of MAP kinases. Cell, 103: 239-252, 2000.
16. Li, P., Nijhawan, D., Budihardjo, I., Srinivasula, S. M., Ahmad, M., Alnemri, E. S., and Wang, X. Cytochrome c and dATP-dependent formation of Apaf-1/caspase-9 complex initiates an apoptotic protease cascade. Cell, 91: 479-489, 1997.
17. MacFarlane, M., Ahmad, M., Srinivasula, S. M., Fernandes-Alnemri, T., Cohen, G. M., and Alnemri, E. S. Identification and molecular cloning of two novel receptors for the cytotoxic ligand TRAIL. J. Biol. Chem., 272: 25417-25420, 1997.
18. Wodicka, L., Dong, H., Mittmann, M., Ho, M. H., and Lockhart, D. J. Genome-wide expression monitoring in Saccharomyces cerevisiae. Nat. Biotechnol., 15: 1359-1367, 1997.
19. Wan, Y., and Nordeen, S. K. Overlapping but distinct gene regulation profiles by glucocorticoids and progestins in human breast cancer cells. Mol. Endocrinol., 16: 1204-1214, 2002.
20. Martell, M., Gomez, J., Esteban, J. I., Sauleda, S., Quer, J., Cabot, B., Esteban, R., and Guardia, J. High-throughput real-time reverse transcription-PCR quantitation of hepatitis C virus RNA. J. Clin. Microbiol., 37: 327-332, 1999.
21. Hibi, M., Lin, A., Smeal, T., Minden, A., and Karin, M. Identification of an oncoprotein- and UV-responsive protein kinase that binds and potentiates the c-Jun activation domain. Genes Dev., 7: 2135-2148, 1993.
22. Kischkel, F. C., Lawrence, D. A., Tinel, A., LeBlanc, H., Virmani, A., Schow, P., Gazdar, A., Blenis, J., Arnott, D., and Ashkenazi, A. Death receptor recruitment of endogenous caspase-10 and apoptosis initiation in the absence of caspase-8. J. Biol. Chem., 276: 46639-46646, 2001.
23. Wang, J., Chun, H. J., Wong, W., Spencer, D. M., and Lenardo. M. J. Caspase-10 is an initiator caspase in death receptor signaling. Proc. Natl. Acad. Sci. USA, 98: 13884-13888, 2001.
24. Ray, C. A., Black, R. A., Kronheim, S. R., Greenstreet, T. A., Sleath, P. R., Salvesen, G. S., and Pickup, D. J. Viral inhibition of inflammation: cowpox virus encodes an inhibitor of the interleukin-1β converting enzyme. Cell, 69: 597-604, 1992.
25. D'Adamio, F., Zollo, O., Moraca, R., Ayroldi, E., Bruscoli, S., Bartoli, A., Cannarile, L., Migliorati, G., and Riccardi, C. A new dexamethasone-induced of the leucine zipper family protects T lymphocytes from TCR/CD3-activated cell death. Immunity, 7: 803-812, 1997.
26. Aljada, A., Ghanim, H., Assian, E., Mohanty, P., Hamouda, W., Garg, R., and Dandona, P. Increased IκB expression and diminished nuclear NF-κB in human mononuclear cells following hydrocortisone injection. J. Clin. Endocrinol. Metab., 84: 3386-3389, 1999.
27. Oka, T., and Perry, J., W. Glucocorticoid stimulation of choline kinase activity during the development of mouse mammary gland. Dev. Biol., 68: 311-318, 1979.
28. Schooltink, H., Schmitz-Van de Leur, H., Heinrich, P. C., and Rose-John, S. Upregulation of the interleukin-6-signal transducing protein (gp130) by interleukin-6 and dexamethasone in HepG2 cells. FEBS Lett., 297: 263-265, 1992.
29. Aebischer, F., and Schlegel-Haueter, S. E. Glucocorticoids modulate the induction of BLTE/granzyme A activity in the murine T-cell hybridoma PC60. Immunopharmacology, 23: 181-190, 1992.
30. Singh, K., Balligand, J. L., Fischer, T. A., Smith, T. W., and Kelly, R. A. Glucocorticoids increase osteopontin expression in cardiac myocytes and microvascular endothelial cells. Role in regulation of inducible nitric oxide synthase. J. Biol. Chem., 270: 28471-28478, 1995.
31. McConkey, D. J., Chandra, J., Wright, S., Plunkett, W., McDonnell, T. J., Reed, J. C., and Keating, M. Apoptosis sensitivity in chronic lymphocytic leukemia is determined by endogenous endonuclease content and relative expression of BCL-2 and BAX. J. Immunol., 156: 2624-2630, 1996.
32. Al Rayyes, O., Wallmark, A., and Floren, C. H. Additive inhibitory effect of hydrocortisone and cyclosporine on low-density lipoprotein receptor activity in cultured HepG2 cells. Hepatology, 26: 967-971, 1997.
33. Ensler, K., Mohammadieh, M., Broijersen, A., Angelin, B., and Gafvels, M. Dexamethasone stimulates very low density lipoprotein (VLDL) receptor gene expression in differentiating 3T3-L1 cells. Biochim. Biophys. Acta, 1581: 36-48, 2002.
34. Cheung, P. T., Wu, J., Banach, W., and Chemausek, S. D. Glucocorticoid regulation of an insulin-like growth factor-binding protein-4 protease produced by a rat neuronal cell line. Endocrinology, 135: 1328-1335, 1994.
35. Wang, X. C., Smith, T. J., and Lau, J. T. Transcriptional regulation of the liver β-galactoside α 2, 6-sialyltransferase by glucocorticoids. J. Biol. Chem., 265: 17849-17853, 1990.
36. Kassel, O., Sancono, A., Kratzschmar, J., Kreft, B., Stassen, M., and Cato, A. C. Glucocorticoids inhibit MAP kinase via increased expression and decreased degradation of MKP-1. EMBO J., 20: 7108-7116, 2001.
37. Keyse, S. M. Protein phosphatases and the regulation of MAP kinase activity. Semin. Cell Dev. Biol., 9: 143-152, 1998.
38. Slack, D. N., Setemes, O. M., Gabrielsen. M., and Keyse, S. M. Distinct binding determinants for ERK2/p38α and JNK map kinases mediate catalytic activation and substrate selectivity of map kinase phosphatase-1. J. Biol. Chem., 276: 16491-16500, 2001.
39. Wang, J., Zheng, L., Lobito, A., Chan, F. K., Dale, J., Sneller, M., Yao, X., Puck, J. M., Straus, S. E., and Lenardo, M. J. Inherited human caspase 10 mutations underlie defective lymphocyte and dendritic cell apoptosis in autoimmune lymphoproliferative syndrome type II. Cell, 98: 47-58, 1999.
40. Miyashita, T., Nagao, K., Krajewski, S., Salvesen, G. S., Reed, J. C., Inoue, T., and Yamada, M. Investigation of glucocorticoid-induced apoptotic pathway: processing of caspase-6 but not caspase-3. Cell Death Differ., 5: 1034-1041, 1998.
41. Hakem, R., Hakem, A., Duncan, G. S., Henderson, J. T., Woo, M., Soengas, M. S., Elia, A., de la Pompa, J. L., Kagi, D., Khoo, W., Potter, J., Yoshida, R., Kaufman, S. A., Lowe, S. W., Penninger, J. M., and Mak, T. W. Differential requirement for caspase 9 in apoptotic pathways in vivo. Cell, 94: 339-352, 1998.
42. Komoriya, A., Packard, B. Z., Brown, M. J., Wu, M. L., and Henkart, P. A. Assessment of caspase activities in intact apoptotic thymocytes using cell-permeable fluorogenic caspase substrates. J. Exp. Med., 191: 1819-1828, 2000.
43. Obexer, P., Certa, U., Kofler, R., and Helmberg, A. Expression profiling of glucocorticoid-treated T-ALL cell lines: rapid repression of multiple genes involved in RNA- protein- and nucleotide synthesis. Oncogene. 20: 4324-4336, 2001.
44. 0 arrested human leukemia cells suggest a mechanism for glucocorticoid-induced apoptosis. FASEB J., 15: 693-699, 2001.
45. Yoshida, N. L., Miyashita, T. U. M., Yamada, M., Reed, J. C., Sugita, Y., and Oshida, T. Analysis of gene expression patterns during glucocorticoid-induced apoptosis using oligonucleotide arrays. Biochem. Biophys. Res. Commun., 293: 1254-1261, 2002.
46. Kino, T., Nordeen, S. K., and Chrousos, G. P. Conditional modulation of glucocorticoid receptor activities by CREB-binding protein (CBP) and p300. J. Steroid Biochem. Mol. Biol., 70: 15-25, 1999.
47. Vottero, A., and Chrousos, G. P. Glucocorticoid Receptor β: view 1. Trends Endocrinol. Metab., 10: 333-338, 1999.
48. Franklin, C. C., Srikanth, S., and Kraft, A. S. Conditional expression of mitogen-activated protein kinase phosphatase-1, MKP-1, is cytoprotective against UV-induced apoptosis. Proc. Natl. Acad. Sci. USA, 95: 3014-3019, 1998.
49. Guo, Y. L., Kang, B., and Williamson, J. R. Inhibition of the expression of mitogen-activated protein phosphatase-1 potentiates apoptosis induced by tumor necrosis factor α in rat mesangial cells. J. Biol. Chem., 273: 10362-10366, 1998.
50. Sanchez-Perez, I., Martinez-Gomariz, M., Williams, D., Keyse, S. M., and Perona, R. CL100/MKP-1 modulates JNK activation and apoptosis in response to cisplatin. Oncogene, 19: 5142-5152, 2000.
51. Srikanth, S., Franklin, C. C., Duke, R. C., and Kraft, R. S. Human DU145 prostate cancer cells overexpressing mitogen-activated protein kinase phosphatase-1 are resistant to Fas ligand-induced mitochondrial perturbations and cellular apoptosis. Mol. Cell. Biochem., 199: 169-178, 1999.
52. Bang, Y. J., Kwon, J. H., Kang, S. H., Kim, J. W., and Yang, Y. C. Increased MAPK activity and MKP-1 overexpression in human gastric adenocarcinoma. Biochem. Biophys. Res. Commun., 250: 43-47, 1998.
53. Kurt, R. A., Urba, W. J., Smith, J. W., and Schoof, D. D. Peripheral T lymphocytes from women with breast cancer exhibit abnormal protein expression of several signaling molecules. Int. J. Cancer, 78: 16-20, 1998.
54. Leppa, S., and Bohmann, D. Diverse functions of JNK signaling and c-Jun in stress response and apoptosis. Oncogene, 18: 6158-6162, 1999.
55. Behrens, A., Sabapathy, K., Graef, I., Cleary, M., Crabtree, G. R., and Wagner, E. F. Jun N-terminal kinase 2 modulates thymocyte apoptosis and T-cell activation through c-Jun and nuclear factor of activated T cell (NF-AT). Proc. Natl. Acad. Sci. USA. 98: 1769-1774, 2001.
56. Mc Gee, M. M., Campiani, G., Ramunno. A., Nacci, V., Lawler, M., Williams, D. C., and Zisterer, D. M. Activation of the c-Jun N-terminal kinase (JNK) signaling pathway is essential during PBOX-6-induced apoptosis in chronic myelogenous leukemia (CML) cells. J. Biol. Chem., 277: 18383-18389, 2002.
57. Harris, C. A., and Johnson, E. M., Jr. BH3-only Bcl-2 family members are coordinately regulated by the JNK pathway and require Bax to induce apoptosis in neurons. J. Biol. Chem., 276: 37754-37760, 2001.